A Multicenter Study of Clinical Epidemiology of Breast Cancer in Shaanxi Province of China

NCT ID: NCT02493569

Last Updated: 2016-08-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to study the epidemic features and diagnosis of female breast cancer, especially the diagnosis and treatment of breast cancer.The disease-free survival (DFS) and the total survival time(OS) of the breast cancer patients will also be studied.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study is a multicentric, retrospective clinical study based on the hospital. The target number of cases are X patients who are eligible for breast cancer after radical mastectomy. To collect the clinicopathological data and treatment data of the breast cancer patients and do the follow-up visit of all the patients who are included in the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Epidemiology breast cancer patients

Observe the features of clinical diagnosis and treatment for female breast cancer patients

The radical mastectomy of breast cancer

Intervention Type PROCEDURE

The radical mastectomy of breast cancer could be used for the treatment of breast cancer during the observation.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

The radical mastectomy of breast cancer

The radical mastectomy of breast cancer could be used for the treatment of breast cancer during the observation.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female patients;
* The hospitalized patients who are confirmed of the primary breast cancer histologically;
* The date of the inpatients are within the month we chosen;
* Patients who are within the month we chosen have been received or under receiving the relevant treatment including surgical treatment, chemotherapy and radiotherapy.

Exclusion Criteria

* Male breast cancer patients;
* Patients with breast cancer who are not under the chosen time;
* Non hospitalized patients.
Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

First Affiliated Hospital Xi'an Jiaotong University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yu Ren, MD,PhD

Role: PRINCIPAL_INVESTIGATOR

First Affiliated Hospital Xi'an Jiaotong University

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yu Ren, MD,PhD

Role: CONTACT

13700222161

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KYLLSL-2015-153-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Familial Breast Cancer in China
NCT06833216 NOT_YET_RECRUITING
Locoregional Recurrence of Breast Cancer
NCT05988112 NOT_YET_RECRUITING
99mTc-ABH2 SPECT/CT in Breast Cancer
NCT06194565 RECRUITING NA